THIS question...this is something I was looking for.
This is excellent. It shares matts position on the United States FDA on american big business.
Matt Schissler Stacey's question - I didn't copy it because we have to limit size of posts
ANS: 2. CBAI is doing great, IMHO. 1. I do think the projections are in line. Big things are brewing. I also believe right now, the grants are little pats on the head to stem cell industry by the govt. Remember who lines the govt's pockets - Big Pharma. but the voters want more in stem cell research. So in order to play both sides against the middle, the gov't hands out small amounts, knowing they won't lead to something that takes down Big Pharma anytime soon. It will take private money to do so. This is all my speculation, so take it for what it is worth.
July 29 at 7:21pm
Matt Schissler Has CBAI considered joining forces with advertising giant Johnson & Johnson (or similar) to create awareness amongst their existing customer base? If so, to what extent and why or why not?
ANS: Yes, it has been considered. But J&J and their competitors all look at cord blood like a Lion looks at a rose bud. "It's pretty, and golly gee its neat, but I have no use for it. It's not going to attack me, and right now, I can't eat it." We've approached many of them, only to be rebuffed because of the relative size of the industry compared to what they do. We are a rounding error to them, right now.
July 29 at 7:17pm
AI
